3Andrew J. Epstein,Scott J. Johnson.Physician response to financial incentives when choosing drugs to treat breast cancer[J].International Journal of Health Care Finance and Economics.2012(4)
4EGGLESTON KAREN.Prescribing institutions: Explaining the evolution of physician dispensing[J].Journal of Institutional Economics.2012(2)
5KarenEggleston,LiLing,MengQingyue,MagnusLindelow,AdamWagstaff.Health service delivery in China: a literature review[J].Health Econ.2008(2)
6ToshiakiIizuka.Experts’ agency problems: evidence from the prescription drug market in Japan[J].The RAND Journal of Economics.2008(3)
7Soonman Kwon.Pharmaceutical reform and physician strikes in Korea: separation of drug prescribing and dispensing[J].Social Science & Medicine.2003(3)
8Winnie Yip,Karen Eggleston.Addressing government and market failures with payment incentives: Hospital reimbursement reform in Hainan, China[J].Social Science & Medicine.2003(2)
9Han Joong Kim,Woojin Chung,Sang Gyu Lee.Lessons from Korea’s pharmaceutical policy reform: the separation of medical institutions and pharmacies for outpatient care[J].Health policy.2003(3)
10BirnaTrap,Ebba H.Hansen.Cotrimoxazole prescribing by dispensing and non‐dispensing doctors: do they differ in rationality?[J].Tropical Medicine & International Health.2002(10)
